Updates on key developments in genomics

Infectious diseases and the race to diagnosis

Researchers are exploring new techniques to tackle serious infectious diseases, and contain an outbreak before it becomes an epidemic

Hereditary haemochromatosis a 'stealth disease’

Recent genomic research has shed new light on the condition, previously thought to be low risk, prompting a review of screening regulation 

Probability, chance and genetic inheritance

When it comes to genetic inheritance from parent to offspring, there isn’t a guaranteed outcome. But there are ways to assess the possible outcomes

Counselling the code: genomic testing and insurance

Genetic counsellor Megan Rogers looks at the new Code on Genetic Testing and Insurance and what it means for patients and counsellors

HIV and the genome

Genome editing has not been without controversies, but some studies suggest it may hold the cure for patients living with HIV

Let’s talk about (biological) sex

Sex as a biological variable has not always been factored in to medical research and practice. Will that change in the era of precision medicine?

Genomics and acute myeloid leukaemia

Aggressive and complex, AML often proves a challenge for clinicians, but genomic analysis is helping in the search for targeted treatments

All I want for Christmas is... a family history

At a time of year when many of us will be getting together with relatives, we explore the value of talking about your family's health

Genomics, the land, and the promise of new drugs

Despite its proven value, scientists and researchers are yet to harness the full medical potential of the soil. Is genomics the key?
Fertilisation IVF

Birth of world’s first gene-edited babies sparks outcry

Why is the procedure so controversial, what are the risks, and could it ever happen in the UK? We take a look at the key issues

Day in the life: clinical bioinformatician

In the latest article in our series, Eileen Gallagher introduces the increasingly important role that bioinformatics plays in today’s healthcare system

Do our genes govern our fate?

A ‘faulty’ gene can result in different outcomes for different people – penetrance and expressivity influence the impact of our genetic code
DNA pills

What is pharmacogenomics?

… and how can clinicians take advantage of advances in genomics to better predict how their patient will respond to medication?

Delivering results: the patient perspective

As genomic testing becomes more prevalent, the ability to deliver results sensitively is paramount; so what matters to your patients and their families?

Unlocking the secrets of the genome

It was once believed that 99% of our genome was made up of ‘junk’ DNA with no purpose. Recent discoveries suggest this is far from the truth

Polygenic risk scores: how useful are they?

Being able to predict an individual’s risk of common conditions is regarded by many as the holy grail. So, where are we now?

Tuberculosis: genome sequencing and new treatment

TB cases are falling worldwide, but with hard-to-treat strains more prevalent than ever, how can genomics help? And what’s new on the treatment horizon?

Your invaluable genome

Genomic data is the currency of a new era of medicine that promises incredible advances. Here, bioinformatician Nana Mensah explains why
microbe-bacteria

Love bugs? Here’s five key facts about the microbiome

The DNA in your body doesn’t just come from you, thanks to the many millions of bacteria, virus and other cells that reside in you and on you

Building on the legacy of the 100,000 Genomes Project

As the pioneering project recruits its last participants, we look forward to the NHS’s plans for a Genomic Medicine Service for all

First RNA-based therapy approved in US and Europe

Gene-silencing technique works without altering the person’s DNA, and prevents harmful proteins from being made in their cells